Skip to main content

Table 1 Patient characteristics and demographics

From: A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of 68Ga-DOTATATE in patients without neuroendocrine tumors

Characteristics Median (range), mean ± SD or n (%)
Sex
 Males 22 (53.7%)
 Females 19 (46.3%)
Age (years) 58 (22–79)
Body weight (kg) 76 (53–120)
Height (cm) 174 (155–196)
Renal function (eGFR; mL/min/1.73m2) 77.5 (61.0–122)
Scan time after injection (min) 47 (35–78)
Administered peptide amount (µg) 12.3 (8.05–16.9)
Administered radioactivity (MBq) 92.7 (43.4–130)
SUVmax
 Aorta 1.59 ± 0.45
 Spleen 21.0 ± 4.50
 Liver 8.52 ± 2.11
 Thyroid 4.42 ± 1.53
SUVpeak
 Aorta 1.17 ± 0.36
 Spleen 19.0 ± 4.19
 Liver 7.16 ± 1.58
 Thyroid 3.20 ± 1.24
  1. SUV: standardized uptake value